The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,200.00
Bid: 11,200.00
Ask: 11,550.00
Change: 0.00 (0.00%)
Spread: 350.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of EWB Solutions Ltd

29 Nov 2016 07:00

RNS Number : 3603Q
Judges Scientific PLC
29 November 2016
 

Press Release

29th November 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of EWB Solutions Ltd

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that it has today acquired 100% of the issued share capital of EWB Solutions Ltd ("EWB" or the "Acquisition"), a maker of scientific devices based in Hemel Hempstead, Hertfordshire. EWB manufactures edge-welded bellows used in Ultra High Vacuum ("UHV") systems and various other applications. The Board expects the Acquisition to be immediately earnings enhancing.

The purchase price of EWB amounted to £1.76 million in cash. An additional payment will be made to reflect any excess working capital over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

Information on EWB

EWB specialises in the design and manufacture of edge-welded bellows. The product is constructed from a series of metal diaphragms, welded to form an accordion like structure that permits free movement between two environments whilst maintaining hermetic separation.

The majority of EWB's products are bespoke and sold directly to original equipment manufacturers ("OEMs") for integration into UHV systems; these provide high tech surface analysis & processing techniques, for use in semi-conductor manufacturing, nano-technology, nuclear science & general research. Other applications include aerospace, medical and industrial devices. Because of the OEM business bias, 85% of sales are within the UK but a significant proportion of EWB products used in system integration are built for export.

EWB was established in 1999 by Peter Moody, Steve Edwards and Bryan Walker, all of whom will continue in their present positions for at least six months to facilitate a smooth transition and may stay for up to two years or more according to their individual choice.

EWB's accounts for the financial year to 30 April 2016 show revenues of £1.2 million and pre-tax profits of £0.5 million. Net tangible assets amounted to £1.6million, including cash of £1.6 million.

EWB's operating profits for the year ended 30 April 2016, adjusted to eliminate non-recurring items and to reflect EWB's ongoing cost base within Judges, would have totalled £0.5m.

The average adjusted EBIT generated by EWB for the five years ended on 30 April 2016 was £0.44 million.

 

Financing of the Acquisition

The consideration for the Acquisition and associated transaction costs have been largely drawn down from the Group's £10 million acquisition facility granted in 2014 by Lloyds Bank Corporate Markets.

The Board believes that EWB is a solid and profitable company making quality products, which will consolidate the Group's pre-eminent position in the UHV field.

 

Alex Hambro, Chairman of Judges, said:

"EWB is an excellent company with quality products which will consolidate our Group's pre-eminent position in the Ultra High Vacuum field. This cash generative acquisition enhances our earnings and fits within the Judges growth model. We are delighted to welcome Peter, Steve, Bryan and their colleagues to Judges' team."

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

Media enquiries:

Abchurch (Financial Public Relations)

 

Julian Bosdet/George Robinson / Rebecca Clube

 

Tel: +44 (0) 20 7398 7741

www.abchurch-group.com

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 15 businesses acquired since it was first admitted to AIM in 2003.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKFDDKBDBDDB
Date   Source Headline
7th Jan 20217:00 amRNSTrading Statement and Notice of Final Results
31st Dec 20207:00 amRNSTotal Voting Rights
10th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Nov 20207:00 amRNSBlock listing Interim Review
12th Nov 20207:00 amRNSCORRECTION: Director/PDMR Shareholding
11th Nov 20204:48 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSGrant of Options
26th Oct 20205:16 pmRNSExercise of Options and Director Dealing
19th Oct 20204:38 pmRNSDirector/PDMR Shareholding
19th Oct 20207:00 amRNSAcquisition of Korvus Technology Ltd
7th Oct 20209:33 amRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSInterim Results
16th Sep 20202:17 pmRNSHolding(s) in Company
10th Sep 202011:25 amRNSDirector/PDMR Shareholding
10th Sep 20207:00 amRNSBoard Change
1st Sep 20209:48 amRNSTotal Voting Rights
11th Aug 20208:24 amRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
21st Jul 20207:00 amRNSTrading Update and Notice of Interim Results
7th Jul 20202:28 pmRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSTotal Voting Rights
8th Jun 20204:03 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSAcquisition of Heath Scientific Company Limited
20th May 20201:55 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Update
15th May 20208:53 amRNSBlock listing Interim Review
14th May 20209:52 amRNSAGM Q&A
7th May 20209:59 amRNSDirector/PDMR Shareholding
30th Apr 20209:52 amRNSTotal Voting Rights
28th Apr 20207:00 amRNSNotice of AGM
8th Apr 202010:23 amRNSDirector/PDMR Shareholding
31st Mar 202011:10 amRNSTotal Voting Rights
18th Mar 20207:00 amRNSFinal Results
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
10th Mar 20208:55 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSStatement regarding COVID-19
7th Feb 20207:00 amRNSDirector/PDMR Shareholding
31st Jan 202010:46 amRNSBlocklisting Application and Total Voting Rights
16th Jan 20203:18 pmRNSExercise of Options and Director Dealing
16th Jan 20207:00 amRNSTrading Statement and Notice of Final Results
13th Jan 20209:37 amRNSDirector/PDMR Shareholding
2nd Jan 20201:42 pmRNSTotal Voting Rights
18th Dec 20198:49 amRNSHolding(s) in Company
6th Dec 20193:01 pmRNSDirector/PDMR Shareholding
6th Dec 20192:40 pmRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSAcquisition of Moorfield Nanotechnology Limited
21st Nov 20197:00 amRNSSpecial dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.